Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists.
暂无分享,去创建一个
[1] T. Greenhalgh,et al. Seeing what you want to see in randomised controlled trials: versions and perversions of UKPDS data , 2000, BMJ : British Medical Journal.
[2] J. Ioannidis,et al. Relative Citation Impact of Various Study Designs in the Health Sciences , 2005, JAMA.
[3] A. Hrõbjartsson,et al. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.
[4] Meir J. Stampfer,et al. Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study , 1998 .
[5] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[6] H. Markovits,et al. The belief-bias effect in the production and evaluation of logical conclusions , 1989, Memory & cognition.
[7] K. Dickersin,et al. Publication Bias: The Problem That Won't Go Away , 1993, Annals of the New York Academy of Sciences.
[8] J. Ioannidis,et al. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias , 2008, PloS one.
[9] B. Bausell,et al. REVIEWING THE REVIEWS , 2001, International Journal of Technology Assessment in Health Care.
[10] D. Sackett,et al. Evidence based medicine: what it is and what it isn't , 1996, BMJ.
[11] E. Wynder,et al. The wish bias. , 1990, Journal of clinical epidemiology.
[12] Xitao Fan,et al. Comparing response rates in e-mail and paper surveys: A meta-analysis , 2009 .
[13] Ross J. Harris,et al. Circulating insulin‐like growth factor peptides and prostate cancer risk: A systematic review and meta‐analysis , 2009, International journal of cancer.
[14] R. Shi,et al. Insulin-like growth factor-I and prostate cancer: a meta-analysis , 2001, British Journal of Cancer.
[15] D. Sackett. Applying overviews and meta-analyses at the bedside. , 1995, Journal of clinical epidemiology.
[16] Richard D Riley,et al. Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.
[17] John P A Ioannidis,et al. Effect of formal statistical significance on the credibility of observational associations. , 2008, American journal of epidemiology.
[18] R Brian Haynes,et al. Evidence based medicine: what it is and what it isn't. 1996. , 2007, Clinical orthopaedics and related research.
[19] T. Kaptchuk,et al. Effect of interpretive bias on research evidence. , 2003, BMJ.
[20] John P A Ioannidis,et al. Reasons or excuses for avoiding meta-analysis in forest plots , 2008, BMJ : British Medical Journal.
[21] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[22] David Moher,et al. Meta-analysis of Observational Studies in Epidemiology , 2000 .
[23] J. Koehler. The Influence of Prior Beliefs on Scientific Judgments of Evidence Quality , 1993 .
[24] S. Thompson,et al. Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.
[25] J. Vandenbroucke,et al. 175th anniversary lecture. Medical journals and the shaping of medical knowledge. , 1998, The Lancet.
[26] G. Guyatt,et al. Going from evidence to recommendations , 2008, BMJ : British Medical Journal.
[27] M. Clarke,et al. Increasing response rates to postal questionnaires: systematic review , 2002, BMJ : British Medical Journal.
[28] Matthias Egger,et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis , 2004, The Lancet.
[29] François G. Meyer,et al. Insulin-like Growth Factors, Their Binding Proteins, and Prostate Cancer Risk: Analysis of Individual Patient Data from 12 Prospective Studies , 2008, Annals of Internal Medicine.
[30] J. Ioannidis,et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. , 2009, Journal of clinical epidemiology.
[31] John P A Ioannidis,et al. Meta‐research: The art of getting it wrong , 2010, Research synthesis methods.
[32] Douglas G Altman,et al. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. , 2010, JAMA.
[33] E. Regidor. Subjective judgements in scientific practice and art , 2022 .
[34] D. English,et al. Circulating Insulin-Like Growth Factor-I and Binding Protein-3 and Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[35] Alan Cantor,et al. The uncertainty principle and industry-sponsored research , 2000, The Lancet.
[36] C. Mantzoros,et al. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. , 1997, British Journal of Cancer.
[37] J. Ioannidis. Why Most Discovered True Associations Are Inflated , 2008, Epidemiology.
[38] J. Ioannidis,et al. Industry sponsorship and selection of comparators in randomized clinical trials , 2010, European journal of clinical investigation.
[39] C. Mantzoros,et al. Hormonal predictors of prostate cancer: a meta-analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] J. Neilson,et al. Statistical methods can be improved within Cochrane pregnancy and childbirth reviews. , 2011, Journal of clinical epidemiology.
[41] B. Margetts. United Kingdom prospective diabetes study , 1995, BMJ.
[42] Chris Todd,et al. Not another questionnaire! Maximizing the response rate, predicting non-response and assessing non-response bias in postal questionnaire studies of GPs. , 2002, Family practice.
[43] K. Dickersin,et al. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. , 1992, JAMA.
[44] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.
[45] George Liberopoulos,et al. Selection in Reported Epidemiological Risks: An Empirical Assessment , 2007, PLoS medicine.
[46] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[47] Andrea Furlan,et al. The interpretation of systematic reviews with meta-analyses: an objective or subjective process? , 2008, BMC Medical Informatics Decis. Mak..
[48] Gordon H Guyatt,et al. Systems for grading the quality of evidence and the strength of recommendations II: Pilot study of a new system , 2005, BMC health services research.
[49] David Moher,et al. Non-Cochrane vs. Cochrane reviews were twice as likely to have positive conclusion statements: cross-sectional study. , 2009, Journal of clinical epidemiology.
[50] N. Wald,et al. Insulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studies , 2006, British Journal of Cancer.
[51] John P A Ioannidis,et al. Statistically significant meta-analyses of clinical trials have modest credibility and inflated effects. , 2011, Journal of clinical epidemiology.
[52] K. Dickersin. How important is publication bias? A synthesis of available data. , 1997, AIDS education and prevention : official publication of the International Society for AIDS Education.
[53] R. MacCoun,et al. Biases in the interpretation and use of research results. , 1998, Annual review of psychology.
[54] D. Altman,et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research , 2004, Canadian Medical Association Journal.